Skip to main content
. 2021 Apr 9;11:652956. doi: 10.3389/fcimb.2021.652956

Figure 3.

Figure 3

IgG and IgG subclasses titers before and after treatment of ML patients. Anti-SLA total IgG (n=15) (A), IgG1 (n=18) (B) and IgG2 (n=18) (C) titers from ML patients, performed by ELISA technique. Statistical analysis was performed by the Wilcoxon signed-rank test. Results are expressed in optical density (OD).